EP2691097 - Bibliographic data
COMPOSITIONS COMPRENANT DE LA NALTREXONE POUR UTILISATION DANS LE TRAITEMENT DE LA SCLÉRODERMIE
| Last update | 10/06/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
IMUNEKS FARMA ILAÇ SANAYI VE TICARET A.S. Pak is Merkezi Prof. Dr. Bülent Tarcan
Sok. No: 5/1
Gayrettepe
34349 Istanbul
Turquie
|
|---|---|
| (72) Inventors |
Ibrahim Mustafa Iskender PISAK Pak Is Merkezi Prof. Dr. Bulent Tarcan Sk. No: 5/1
Gayrettepe / Istanbul 34349
Turquie
Mehmet PISAK Pak Is Merkezi Prof. Dr. Bulent Tarcan Sk. No: 5/1
Gayrettepe / Istanbul 34349
Turquie
Mehmet Levent SELAMOGLU Pak Is Merkezi Prof. Dr. Bulent Tarcan Sk. No: 5/1
Gayrettepe / Istanbul 34349
Turquie
Semra BINGOL Pak Is Merkezi Prof. Dr. Bulent Tarcan Sk. No: 5/1
Gayrettepe / Istanbul 34349
Turquie
|
| (74) Agent |
Mail recipient Kodron, Felix Rechtsanwalt
Postfach 2649
55016 Mainz
Allemagne
|
| (21) Request number | EP11720901.5 |
|---|---|
| (22) Request date | 31/03/2011 |
| (11) Publication number | EP2691097 |
|---|---|
| Publication date | 20/12/2017 |
| (54) Title of the invention | COMPOSITIONS COMPRENANT DE LA NALTREXONE POUR UTILISATION DANS LE TRAITEMENT DE LA SCLÉRODERMIE |
|---|---|
| (51) International classification | A61K 31/485, A61P 43/00, A61K 9/48, A61K 9/06, A61K 9/00 |
| International classification (before reform) | None |
| Claimed priority | |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 8 -
Amount: 135 € -
Due date 03/04/2018
Surtax: 8 - Amount: 27 € - Due date 04/10/2018 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 20/12/2017 Entrée en période de grâce du brevet d'invention - Legal date 04/04/2018 Déchéance du brevet d'invention après période de grâce - Legal date 03/04/2018 |